Journey of siRNA: Clinical Developments and Targeted Delivery

Since the evolutionary discovery of RNA interference and its utilization for gene knockdown in mammalian cell, a remarkable progress has been achieved in small interfering RNA (siRNA) therapeutics. siRNA is a promising tool, utilized as therapeutic agent against various diseases. Despite its signifi...

Full description

Saved in:
Bibliographic Details
Published inNucleic acid therapeutics Vol. 28; no. 4; pp. 29 - 224
Main Authors Nikam, Rahul R., Gore, Kiran R.
Format Journal Article
LanguageEnglish
Published United States Mary Ann Liebert, Inc 01.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Since the evolutionary discovery of RNA interference and its utilization for gene knockdown in mammalian cell, a remarkable progress has been achieved in small interfering RNA (siRNA) therapeutics. siRNA is a promising tool, utilized as therapeutic agent against various diseases. Despite its significant potential benefits, safe, efficient, and target oriented delivery of siRNA is one of the major challenges in siRNA therapeutics. This review covers major achievements in clinical trials and targeted delivery of siRNAs using various targeting ligand-receptor pair. Local and systemically administered siRNA drug candidates at various phases in clinical trials are described in this review. This review also provides a deep insight in development of targeted delivery of siRNA. Various targeting ligand-siRNA pair with complexation and conjugation approaches are discussed in this review. This will help to achieve further optimization and development in targeted delivery of siRNAs to achieve higher gene silencing efficiency with lowest siRNA dose availability.
AbstractList Since the evolutionary discovery of RNA interference and its utilization for gene knockdown in mammalian cell, a remarkable progress has been achieved in small interfering RNA (siRNA) therapeutics. siRNA is a promising tool, utilized as therapeutic agent against various diseases. Despite its significant potential benefits, safe, efficient, and target oriented delivery of siRNA is one of the major challenges in siRNA therapeutics. This review covers major achievements in clinical trials and targeted delivery of siRNAs using various targeting ligand-receptor pair. Local and systemically administered siRNA drug candidates at various phases in clinical trials are described in this review. This review also provides a deep insight in development of targeted delivery of siRNA. Various targeting ligand-siRNA pair with complexation and conjugation approaches are discussed in this review. This will help to achieve further optimization and development in targeted delivery of siRNAs to achieve higher gene silencing efficiency with lowest siRNA dose availability.
Author Gore, Kiran R.
Nikam, Rahul R.
Author_xml – sequence: 1
  givenname: Rahul R.
  surname: Nikam
  fullname: Nikam, Rahul R.
– sequence: 2
  givenname: Kiran R.
  surname: Gore
  fullname: Gore, Kiran R.
  email: kiran.gore@chem.mu.ac.in
  organization: Department of Chemistry, University of Mumbai, Mumbai, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29584585$$D View this record in MEDLINE/PubMed
BookMark eNqF0M1LwzAYBvAgiptzR69S8OKlM2mSJhE8jPnNUJB5Lmn6Vjq6dCbtYP-9KZs7eDGXhOTHw5vnDB3bxgJCFwRPCJbqxup2kmAiJlgQfoSGCeEqppTx48OZigEae7_EYXGMmeSnaJAoLhmXfIjuXpvOWdhGTRn56uNtehvN6spWRtfRPWygbtYrsK2PtC2ihXZf0EIRXupqA257jk5KXXsY7_cR-nx8WMye4_n708tsOo8No6SNqaBaqjwtRW7yhCtTQpHnhBGRaClooos0NUTKEstSMMAFBRBGpSbIFIqEjtD1Lnftmu8OfJutKm-grrWFpvNZ6ECxlCqOA736Q5f9D8N0QcngsGAsqHinjGu8d1Bma1ettNtmBGd9tVmoto8VWV9t8Jf71C5fQXHQv0UGQHegv9bW1hXk4Np_Yn8A7OOFqw
CitedBy_id crossref_primary_10_1093_nar_gkac945
crossref_primary_10_1016_j_ijbiomac_2023_124582
crossref_primary_10_1002_ijch_201900176
crossref_primary_10_1002_mabi_201900152
crossref_primary_10_1093_nar_gkac308
crossref_primary_10_1021_acs_chemrev_1c00244
crossref_primary_10_1002_smtd_201800365
crossref_primary_10_1016_j_apsb_2021_08_009
crossref_primary_10_1007_s13346_020_00724_5
crossref_primary_10_1016_j_omtn_2023_04_013
crossref_primary_10_1002_jmv_28586
crossref_primary_10_1016_j_lfs_2020_118895
crossref_primary_10_1038_s41409_020_0966_6
crossref_primary_10_3390_pharmaceutics13030380
crossref_primary_10_3390_ijms25094692
crossref_primary_10_1016_j_bbcan_2020_188454
crossref_primary_10_1021_acs_nanolett_2c01994
crossref_primary_10_1089_nat_2018_0745
crossref_primary_10_3390_antibiotics9100702
crossref_primary_10_1002_slct_202301858
crossref_primary_10_3389_fphar_2021_623674
crossref_primary_10_3389_fbioe_2020_00069
crossref_primary_10_3390_nano12030524
crossref_primary_10_1021_acs_jafc_3c03721
crossref_primary_10_1016_j_jtbi_2022_111055
crossref_primary_10_3389_fbioe_2023_1268454
crossref_primary_10_1016_j_antiviral_2022_105366
crossref_primary_10_1111_bph_15414
crossref_primary_10_1021_acschembio_1c00652
crossref_primary_10_3389_fonc_2022_827891
crossref_primary_10_5582_irdr_2020_03089
crossref_primary_10_1186_s12951_023_02081_0
crossref_primary_10_1093_eurheartj_ehaa229
crossref_primary_10_1016_j_ejmech_2022_114142
crossref_primary_10_1002_anbr_202300132
crossref_primary_10_2147_IJN_S321329
crossref_primary_10_1002_btm2_10215
crossref_primary_10_1021_acs_molpharmaceut_3c00455
crossref_primary_10_1021_acs_joc_3c02506
crossref_primary_10_1159_000524990
crossref_primary_10_1016_j_jconrel_2019_09_004
crossref_primary_10_1002_slct_202203476
crossref_primary_10_1093_cei_uxac116
crossref_primary_10_1089_nat_2020_0882
crossref_primary_10_1007_s10495_019_01571_7
crossref_primary_10_1021_acsabm_2c00063
crossref_primary_10_1038_s41467_022_34262_0
crossref_primary_10_1080_15569527_2022_2050746
crossref_primary_10_1186_s12885_022_09612_2
crossref_primary_10_3390_pharmaceutics14020341
crossref_primary_10_1002_cbin_11841
crossref_primary_10_1021_acsabm_1c01182
crossref_primary_10_1016_j_procbio_2019_06_025
crossref_primary_10_2174_1567201816666191112113031
crossref_primary_10_1016_j_dld_2022_07_017
crossref_primary_10_1021_acsabm_1c00003
crossref_primary_10_1177_2472555220960045
crossref_primary_10_1049_iet_nbt_2018_5286
crossref_primary_10_1016_j_biopha_2022_112672
crossref_primary_10_3390_ijms232012071
crossref_primary_10_1016_j_bone_2020_115578
crossref_primary_10_1016_j_matdes_2021_110197
crossref_primary_10_3390_pharmaceutics13111901
crossref_primary_10_1002_cac2_12223
crossref_primary_10_1016_j_mtbio_2021_100105
crossref_primary_10_3389_fbioe_2022_929243
crossref_primary_10_1016_j_bmc_2024_117616
crossref_primary_10_1080_07328303_2019_1708374
crossref_primary_10_1021_acs_molpharmaceut_3c00397
crossref_primary_10_1016_j_heliyon_2024_e27307
crossref_primary_10_1080_09205063_2021_1992589
crossref_primary_10_4274_imj_galenos_2022_83707
crossref_primary_10_21769_BioProtoc_3685
crossref_primary_10_3390_ijms24010319
crossref_primary_10_1007_s00726_021_02961_5
crossref_primary_10_1007_s10565_022_09761_x
crossref_primary_10_2174_0109298673237968231106095141
crossref_primary_10_1136_jnnp_2019_322327
crossref_primary_10_3389_fcell_2020_593269
crossref_primary_10_1016_j_colsurfb_2022_112753
crossref_primary_10_1016_j_omtn_2020_07_012
crossref_primary_10_1021_acs_jmedchem_2c00024
crossref_primary_10_36233_0507_4088_2020_65_4_182_190
crossref_primary_10_3389_fcimb_2023_1305510
crossref_primary_10_1007_s11883_019_0791_9
crossref_primary_10_1021_acs_molpharmaceut_9b00800
crossref_primary_10_1016_j_ijbiomac_2021_10_138
crossref_primary_10_1002_ejoc_202001348
crossref_primary_10_1089_nat_2022_0021
crossref_primary_10_1007_s40291_019_00438_6
crossref_primary_10_1002_cm_21768
crossref_primary_10_3390_ijms25137292
crossref_primary_10_1016_j_apsb_2022_07_010
crossref_primary_10_3389_fgene_2022_921051
crossref_primary_10_3389_fphar_2019_00444
crossref_primary_10_1039_D1RA04293A
crossref_primary_10_1021_acsanm_3c02618
crossref_primary_10_1002_chem_202301928
crossref_primary_10_1039_D0BM01420F
crossref_primary_10_1007_s10787_023_01217_w
crossref_primary_10_3390_cancers12113159
crossref_primary_10_3390_biomedicines8110497
crossref_primary_10_15407_biotech12_03_041
crossref_primary_10_1016_j_bcp_2021_114469
crossref_primary_10_1021_acs_molpharmaceut_0c01238
crossref_primary_10_1002_adma_202104139
crossref_primary_10_1016_j_ejps_2019_105159
crossref_primary_10_1016_j_ncrna_2023_05_008
crossref_primary_10_1016_j_ijpharm_2019_06_023
crossref_primary_10_1016_j_biopha_2021_111633
crossref_primary_10_1101_cshperspect_a041313
crossref_primary_10_5005_jp_journals_11002_0012
crossref_primary_10_1016_j_jconrel_2021_09_011
crossref_primary_10_1039_C9NR06187H
crossref_primary_10_1002_biot_202000079
crossref_primary_10_1016_j_jconrel_2020_11_005
crossref_primary_10_1167_iovs_64_14_16
crossref_primary_10_1002_tcr_202200174
crossref_primary_10_1016_j_gene_2021_146025
Cites_doi 10.18632/oncotarget.4183
10.1002/cbic.201500023
10.1038/nrd2310
10.1016/j.alcohol.2008.12.007
10.1038/35052556
10.1517/14728222.2011.538682
10.1089/oli.2008.0164
10.1681/ASN.2013070780
10.1038/nrg3978
10.1038/mt.2013.291
10.1016/j.bbrc.2006.02.049
10.3390/ijms9030299
10.1093/nar/gkn042
10.1146/annurev.bioeng.8.061505.095848
10.1021/cb300078e
10.1093/nar/gkn958
10.1038/nrd2742
10.3390/ijms160817589
10.1016/S0040-4020(98)00094-5
10.1016/j.addr.2007.03.005
10.1038/sj.cr.7290248
10.1038/35888
10.3390/ph6020223
10.1038/35078107
10.1016/j.ijpharm.2015.12.055
10.1002/adhm.201600057
10.1089/nat.2014.0489
10.1021/acs.molpharmaceut.5b00575
10.18632/oncotarget.7076
10.1016/j.chembiol.2011.12.008
10.4137/OED.S4878
10.1021/bc800249n
10.1182/blood.V124.21.1606.1606
10.1016/j.tet.2008.08.117
10.1038/nature08956
10.1038/nbt.3810
10.1021/ja505986a
10.1111/j.1742-4658.2010.07904.x
10.1021/acs.molpharmaceut.6b00646
10.1021/bi0343774
10.1208/s12248-010-9210-4
10.1002/ajh.24543
10.1016/j.biomaterials.2012.07.012
10.1016/j.biomaterials.2014.05.021
10.1073/pnas.1322937111
10.1016/j.bmc.2009.02.001
10.1021/jo202666m
10.1021/cr050009p
10.1128/MMBR.67.4.657-685.2003
10.1186/gb-2008-9-2-210
10.1038/nmat3765
10.1021/jm050044o
10.1111/j.1365-2796.2009.02191.x
10.1016/j.healun.2015.08.012
10.1016/j.omtn.2017.06.005
10.1038/srep30346
10.1146/annurev-pharmtox-010715-103633
10.1038/mt.2013.216
10.1038/nbt.1560
10.1038/sj.cgt.7700931
10.1016/j.addr.2009.04.018
10.1089/oli.2011.0278
10.1038/nrd3010
10.1038/nbt1223
10.1186/s13073-017-0450-0
10.1016/S0140-6736(13)61914-5
10.1016/j.mattod.2014.05.002
10.1111/j.1365-2958.1992.tb02202.x
10.1016/S0092-8674(03)00801-8
10.5414/CPP50076
10.1261/rna.25706
10.1016/j.addr.2015.01.007
10.1111/j.1365-2796.2009.02189.x
10.1016/j.ijpharm.2016.06.127
10.1039/b900880b
10.1093/nar/gki193
10.1016/j.addr.2016.06.011
10.1016/j.ijpharm.2016.06.125
10.1016/j.jconrel.2012.12.017
10.1371/journal.pmed.1001997
10.1016/j.bbrc.2007.06.177
10.1016/j.cell.2009.01.035
10.1038/srep24867
10.3390/nano6080141
10.1158/1535-7163.MCT-16-0541
10.1016/j.bbrc.2004.04.175
10.1172/JCI33494
10.1093/nar/gkp106
10.1097/IAE.0b013e3181ad2341
10.1093/nar/gkr1301
10.1016/j.jconrel.2016.03.029
10.1016/S0092-8674(04)00293-4
10.4161/cc.5.18.3192
10.1038/nsmb.1673
10.3109/13506129.2016.1160882
10.1007/s13346-016-0348-1
10.1200/jco.2011.29.15_suppl.3025
10.1039/B611612D
10.1128/AAC.00014-09
10.1016/j.cell.2005.06.023
10.1016/0092-8674(95)90082-9
10.1002/path.2993
10.1038/nchembio1207-739
10.3390/ph6030287
10.1038/nm725
10.1093/nar/gkl033
10.1093/nar/gkn342
10.2147/IJN.S106625
10.1038/mt.2009.273
10.1242/jcs.066399
10.1186/1758-907X-1-14
10.1038/nature02873
10.1073/pnas.1411393111
10.1002/cmdc.200900444
10.1038/418244a
10.1016/j.biomaterials.2008.04.036
10.1016/j.ajo.2010.02.006
10.1038/nrd4685
10.1167/iovs.16-20303
10.1016/j.ajps.2014.08.011
10.1038/nbt1081
10.1016/j.molmed.2015.01.001
10.1016/j.ymthe.2016.10.019
10.1016/j.tibtech.2010.07.009
10.1038/nrm2085
10.1105/tpc.2.4.279
10.1186/s13023-015-0326-6
10.1039/C6CC10287E
10.1093/nar/gkw236
10.1016/j.cell.2005.08.044
10.1016/j.cell.2005.10.020
10.1002/smll.201501985
10.1182/blood.V126.23.2413.2413
10.1200/jco.2015.33.15_suppl.11006
10.1038/nature14442
10.1038/mtna.2015.36
10.3390/molecules22010139
10.1021/acs.langmuir.5b01979
10.1093/nar/gkg393
10.1016/j.addr.2015.02.002
10.1002/anie.201510844
10.1089/oli.2008.0168
10.1016/j.coph.2012.05.004
10.1016/j.jconrel.2015.02.003
10.1016/j.chembiol.2012.07.011
10.1038/srep21881
10.1038/srep21422
ContentType Journal Article
Copyright 2018, Mary Ann Liebert, Inc.
(©) Copyright 2018, Mary Ann Liebert, Inc.
Copyright_xml – notice: 2018, Mary Ann Liebert, Inc.
– notice: (©) Copyright 2018, Mary Ann Liebert, Inc.
DBID NPM
AAYXX
CITATION
3V.
7QL
7T5
7TM
7TO
7U9
7X7
7XB
88A
88E
88I
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PQEST
PQQKQ
PQUKI
Q9U
RC3
7X8
DOI 10.1089/nat.2017.0715
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Science Journals
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest Central Student
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2159-3345
EndPage 224
ExternalDocumentID 10_1089_nat_2017_0715
29584585
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Mumbai India
India
GeographicLocations_xml – name: India
– name: Mumbai India
GroupedDBID ---
-IN
0R~
4.4
53G
7X7
88A
88E
88I
8C1
8FE
8FH
8FI
8FJ
ABBKN
ABJNI
ABUWG
ACGFS
ACGOD
ACPRK
ADBBV
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BNQNF
BPHCQ
BVXVI
CCPQU
DWQXO
EBS
EJD
FYUFA
GNUQQ
HCIFZ
HMCUK
IM4
LK8
M0L
M1P
M2P
M7P
O9-
PQQKQ
PROAC
PSQYO
RML
UE5
UKHRP
1-M
3V.
NPM
AAYXX
CITATION
123
29N
7QL
7T5
7TM
7TO
7U9
7XB
8FD
8FK
AFFNX
C1K
CS3
DU5
F5P
FR3
H94
IAO
IHR
K9.
MV1
NQHIM
P64
PQEST
PQUKI
Q9U
RC3
7X8
ID FETCH-LOGICAL-c431t-373a89b6f7bcb259cfedbb14172a8732ad66c188f08f74e0d3ee7c96c9cf6ed23
IEDL.DBID 8C1
ISSN 2159-3337
IngestDate Thu Aug 15 23:45:45 EDT 2024
Fri Oct 04 09:07:39 EDT 2024
Thu Sep 26 19:20:13 EDT 2024
Sat Sep 28 08:37:44 EDT 2024
Fri Sep 27 01:23:06 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords clinical trial
gene silencing
targeted delivery
siRNA
RNA interference
GalNAc
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c431t-373a89b6f7bcb259cfedbb14172a8732ad66c188f08f74e0d3ee7c96c9cf6ed23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 29584585
PQID 2080190744
PQPubID 40361
PageCount 196
ParticipantIDs proquest_miscellaneous_2019463950
proquest_journals_2080190744
crossref_primary_10_1089_nat_2017_0715
pubmed_primary_29584585
maryannliebert_primary_10_1089_nat_2017_0715
PublicationCentury 2000
PublicationDate 20180801
2018-08-00
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 08
  year: 2018
  text: 20180801
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New Rochelle
PublicationTitle Nucleic acid therapeutics
PublicationTitleAlternate Nucleic Acid Ther
PublicationYear 2018
Publisher Mary Ann Liebert, Inc
Publisher_xml – name: Mary Ann Liebert, Inc
References B20
B21
B22
B23
B24
B25
B26
B27
B28
B29
Hill A (B110) 2015; 126
B158
B159
B156
B157
B154
B155
B152
B153
B151
B30
B31
B32
B34
B35
B37
B39
B169
B167
B1
B168
B2
B165
B3
B166
B4
B163
B5
B164
B6
B161
B7
B162
B8
B9
B160
B43
B45
B48
B178
B179
B176
Sioud M (B117) 2009; 487
B177
B174
B175
B172
B173
B170
B171
B51
B52
Gonzalez V (B46) 2014; 55
B53
B54
B55
B57
B106
B103
B104
B102
B100
B181
B180
B60
B62
B64
B65
B66
B67
B68
B69
B118
B119
B116
Borodovsky A (B109) 2014; 124
B114
B115
B113
B111
B70
B71
B74
B75
B76
Lee JM (B150) 2013; 2013
B77
B78
Burnett JC (B36) 2011; 6
B129
B127
B128
B125
B126
B123
B124
B121
B122
B120
B80
B81
B84
B88
B89
Tolcher AW (B86) 2015; 33
B138
B139
B136
B137
B134
B135
B132
B133
B130
B131
B91
B92
B93
B95
B96
B10
B98
B11
B12
B13
B14
B15
B16
B17
Ruz V (B42) 2014; 55
B18
B19
B149
B147
B148
B145
B146
B143
B144
B141
B142
B140
Dejneka NS (B33) 2008; 14
References_xml – ident: B62
  doi: 10.18632/oncotarget.4183
– ident: B174
  doi: 10.1002/cbic.201500023
– ident: B29
  doi: 10.1038/nrd2310
– ident: B98
  doi: 10.1016/j.alcohol.2008.12.007
– ident: B1
  doi: 10.1038/35052556
– ident: B88
  doi: 10.1517/14728222.2011.538682
– ident: B130
  doi: 10.1089/oli.2008.0164
– ident: B71
  doi: 10.1681/ASN.2013070780
– ident: B102
  doi: 10.1038/nrg3978
– ident: B100
  doi: 10.1038/mt.2013.291
– ident: B138
  doi: 10.1016/j.bbrc.2006.02.049
– ident: B128
  doi: 10.3390/ijms9030299
– ident: B140
  doi: 10.1093/nar/gkn042
– ident: B145
  doi: 10.1146/annurev.bioeng.8.061505.095848
– ident: B124
  doi: 10.1021/cb300078e
– ident: B137
  doi: 10.1093/nar/gkn958
– ident: B26
  doi: 10.1038/nrd2742
– ident: B96
  doi: 10.3390/ijms160817589
– ident: B132
  doi: 10.1016/S0040-4020(98)00094-5
– ident: B21
  doi: 10.1016/j.addr.2007.03.005
– ident: B4
  doi: 10.1038/sj.cr.7290248
– ident: B19
  doi: 10.1038/35888
– ident: B52
  doi: 10.3390/ph6020223
– ident: B20
  doi: 10.1038/35078107
– ident: B154
  doi: 10.1016/j.ijpharm.2015.12.055
– ident: B171
  doi: 10.1002/adhm.201600057
– ident: B39
  doi: 10.1089/nat.2014.0489
– ident: B162
  doi: 10.1021/acs.molpharmaceut.5b00575
– ident: B167
  doi: 10.18632/oncotarget.7076
– ident: B34
  doi: 10.1016/j.chembiol.2011.12.008
– ident: B32
  doi: 10.4137/OED.S4878
– ident: B169
  doi: 10.1021/bc800249n
– volume: 124
  start-page: 1606
  year: 2014
  ident: B109
  publication-title: Blood
  doi: 10.1182/blood.V124.21.1606.1606
  contributor:
    fullname: Borodovsky A
– ident: B131
  doi: 10.1016/j.tet.2008.08.117
– ident: B74
  doi: 10.1038/nature08956
– ident: B103
  doi: 10.1038/nbt.3810
– ident: B173
  doi: 10.1021/ja505986a
– ident: B119
  doi: 10.1111/j.1742-4658.2010.07904.x
– ident: B155
  doi: 10.1021/acs.molpharmaceut.6b00646
– ident: B133
  doi: 10.1021/bi0343774
– ident: B143
  doi: 10.1208/s12248-010-9210-4
– ident: B104
  doi: 10.1002/ajh.24543
– ident: B156
  doi: 10.1016/j.biomaterials.2012.07.012
– ident: B177
  doi: 10.1016/j.biomaterials.2014.05.021
– ident: B153
  doi: 10.1073/pnas.1322937111
– ident: B127
  doi: 10.1016/j.bmc.2009.02.001
– ident: B122
  doi: 10.1021/jo202666m
– ident: B125
  doi: 10.1021/cr050009p
– ident: B22
  doi: 10.1128/MMBR.67.4.657-685.2003
– ident: B8
  doi: 10.1186/gb-2008-9-2-210
– ident: B91
  doi: 10.1038/nmat3765
– ident: B135
  doi: 10.1021/jm050044o
– ident: B144
  doi: 10.1111/j.1365-2796.2009.02191.x
– ident: B51
  doi: 10.1016/j.healun.2015.08.012
– ident: B57
  doi: 10.1016/j.omtn.2017.06.005
– ident: B181
  doi: 10.1038/srep30346
– ident: B106
  doi: 10.1146/annurev-pharmtox-010715-103633
– ident: B45
  doi: 10.1038/mt.2013.216
– ident: B180
  doi: 10.1038/nbt.1560
– ident: B3
  doi: 10.1038/sj.cgt.7700931
– ident: B65
  doi: 10.1016/j.addr.2009.04.018
– volume: 2013
  start-page: 782041
  year: 2013
  ident: B150
  publication-title: Biomed Res Int
  contributor:
    fullname: Lee JM
– ident: B176
  doi: 10.1089/oli.2011.0278
– ident: B115
  doi: 10.1038/nrd3010
– ident: B179
  doi: 10.1038/nbt1223
– volume: 487
  start-page: 41
  year: 2009
  ident: B117
  publication-title: Methods Mol Biol
  contributor:
    fullname: Sioud M
– ident: B60
  doi: 10.1186/s13073-017-0450-0
– ident: B92
  doi: 10.1016/S0140-6736(13)61914-5
– ident: B24
  doi: 10.1016/j.mattod.2014.05.002
– ident: B17
  doi: 10.1111/j.1365-2958.1992.tb02202.x
– ident: B15
  doi: 10.1016/S0092-8674(03)00801-8
– ident: B78
  doi: 10.5414/CPP50076
– ident: B139
  doi: 10.1261/rna.25706
– ident: B28
  doi: 10.1016/j.addr.2015.01.007
– ident: B149
  doi: 10.1111/j.1365-2796.2009.02189.x
– ident: B160
  doi: 10.1016/j.ijpharm.2016.06.127
– ident: B67
  doi: 10.1039/b900880b
– ident: B134
  doi: 10.1093/nar/gki193
– ident: B147
  doi: 10.1016/j.addr.2016.06.011
– ident: B165
  doi: 10.1016/j.ijpharm.2016.06.125
– ident: B172
  doi: 10.1016/j.jconrel.2012.12.017
– ident: B95
  doi: 10.1371/journal.pmed.1001997
– ident: B142
  doi: 10.1016/j.bbrc.2007.06.177
– ident: B10
  doi: 10.1016/j.cell.2009.01.035
– ident: B158
  doi: 10.1038/srep24867
– ident: B157
  doi: 10.3390/nano6080141
– volume: 14
  start-page: 997
  year: 2008
  ident: B33
  publication-title: Mol Vis
  contributor:
    fullname: Dejneka NS
– ident: B89
  doi: 10.1158/1535-7163.MCT-16-0541
– ident: B116
  doi: 10.1016/j.bbrc.2004.04.175
– ident: B27
  doi: 10.1172/JCI33494
– ident: B141
  doi: 10.1093/nar/gkp106
– ident: B31
  doi: 10.1097/IAE.0b013e3181ad2341
– ident: B126
  doi: 10.1093/nar/gkr1301
– ident: B168
  doi: 10.1016/j.jconrel.2016.03.029
– ident: B7
  doi: 10.1016/S0092-8674(04)00293-4
– ident: B151
  doi: 10.4161/cc.5.18.3192
– ident: B12
  doi: 10.1038/nsmb.1673
– ident: B68
  doi: 10.3109/13506129.2016.1160882
– ident: B170
  doi: 10.1007/s13346-016-0348-1
– ident: B80
  doi: 10.1200/jco.2011.29.15_suppl.3025
– ident: B114
  doi: 10.1039/B611612D
– volume: 6
  start-page: 1130
  year: 2011
  ident: B36
  publication-title: Biotech
  contributor:
    fullname: Burnett JC
– ident: B48
  doi: 10.1128/AAC.00014-09
– ident: B13
  doi: 10.1016/j.cell.2005.06.023
– ident: B18
  doi: 10.1016/0092-8674(95)90082-9
– ident: B23
  doi: 10.1002/path.2993
– ident: B25
  doi: 10.1038/nchembio1207-739
– ident: B5
  doi: 10.3390/ph6030287
– ident: B69
  doi: 10.1038/nm725
– ident: B136
  doi: 10.1093/nar/gkl033
– ident: B146
  doi: 10.1093/nar/gkn342
– ident: B70
  doi: 10.2147/IJN.S106625
– ident: B54
  doi: 10.1038/mt.2009.273
– ident: B148
  doi: 10.1242/jcs.066399
– ident: B37
  doi: 10.1186/1758-907X-1-14
– ident: B6
  doi: 10.1038/nature02873
– ident: B75
  doi: 10.1073/pnas.1411393111
– volume: 55
  start-page: 564
  year: 2014
  ident: B46
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Gonzalez V
– ident: B120
  doi: 10.1002/cmdc.200900444
– ident: B2
  doi: 10.1038/418244a
– ident: B66
  doi: 10.1016/j.biomaterials.2008.04.036
– ident: B35
  doi: 10.1016/j.ajo.2010.02.006
– ident: B76
  doi: 10.1038/nrd4685
– ident: B43
  doi: 10.1167/iovs.16-20303
– volume: 55
  start-page: 3673
  year: 2014
  ident: B42
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Ruz V
– ident: B64
  doi: 10.1016/j.ajps.2014.08.011
– ident: B118
  doi: 10.1038/nbt1081
– ident: B84
  doi: 10.1016/j.molmed.2015.01.001
– ident: B175
  doi: 10.1016/j.ymthe.2016.10.019
– ident: B30
  doi: 10.1016/j.tibtech.2010.07.009
– ident: B14
  doi: 10.1038/nrm2085
– ident: B16
  doi: 10.1105/tpc.2.4.279
– ident: B81
  doi: 10.1186/s13023-015-0326-6
– ident: B178
  doi: 10.1039/C6CC10287E
– ident: B123
  doi: 10.1093/nar/gkw236
– ident: B11
  doi: 10.1016/j.cell.2005.08.044
– ident: B9
  doi: 10.1016/j.cell.2005.10.020
– ident: B166
  doi: 10.1002/smll.201501985
– volume: 126
  start-page: 2413
  year: 2015
  ident: B110
  publication-title: Blood
  doi: 10.1182/blood.V126.23.2413.2413
  contributor:
    fullname: Hill A
– volume: 33
  start-page: 11006
  year: 2015
  ident: B86
  publication-title: J Clin Oncol
  doi: 10.1200/jco.2015.33.15_suppl.11006
  contributor:
    fullname: Tolcher AW
– ident: B93
  doi: 10.1038/nature14442
– ident: B111
  doi: 10.1038/mtna.2015.36
– ident: B53
  doi: 10.3390/molecules22010139
– ident: B164
  doi: 10.1021/acs.langmuir.5b01979
– ident: B129
  doi: 10.1093/nar/gkg393
– ident: B152
  doi: 10.1016/j.addr.2015.02.002
– ident: B161
  doi: 10.1002/anie.201510844
– ident: B163
  doi: 10.1089/oli.2008.0168
– ident: B77
  doi: 10.1016/j.coph.2012.05.004
– ident: B113
  doi: 10.1016/j.jconrel.2015.02.003
– ident: B121
  doi: 10.1016/j.chembiol.2012.07.011
– ident: B159
  doi: 10.1038/srep21881
– ident: B55
  doi: 10.1038/srep21422
SSID ssj0000500485
ssj0025807
Score 2.5716333
SecondaryResourceType review_article
Snippet Since the evolutionary discovery of RNA interference and its utilization for gene knockdown in mammalian cell, a remarkable progress has been achieved in small...
SourceID proquest
crossref
pubmed
maryannliebert
SourceType Aggregation Database
Index Database
Publisher
StartPage 29
SubjectTerms Biological evolution
Cancer
Chemical compounds
Clinical trials
Conjugation
Drug development
Enzymes
Gene expression
Gene silencing
Glaucoma
Hypertension
Infections
Ligands
Macular degeneration
Medical research
Pain
Peptides
Pharmaceuticals
Pharmacology
Proteins
Review
Reviews
Ribonucleic acid
RNA
RNA-mediated interference
siRNA
Vascular endothelial growth factor
Title Journey of siRNA: Clinical Developments and Targeted Delivery
URI https://www.liebertpub.com/doi/abs/10.1089/nat.2017.0715
https://www.ncbi.nlm.nih.gov/pubmed/29584585
https://www.proquest.com/docview/2080190744/abstract/
https://search.proquest.com/docview/2019463950
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTxsxEB5BuPQAoqVAWhoZqeLUVfbltc2lSiNQVKkRQiDltvJTQgq7QMIh_56Z3U1aDtCzLY88fsw39jczAN-TRKdOGhsFrXiUe24iw9FxTblMyIBZm1Hs8J9pMbnNf8_4bAsm61gYolWu78Tmona1pTdydNIlhT2LPB9qQ68Adjn8-fAYUf0o-mftimlsw06CW5SKOMjxhuyBkpvAabRvKsqyTHTZNmOphpUmSmUiKFUff2Wddil4TFcVgkEiOb-NQRtbdLkPex2IZKN21T_Clq8-wcEIZdT3K3bGGlpn815-AC3k9CtWB7a4u56OzlmXC3TO_mEMLZiuHLtpeOHeYcucCBurz3B7eXEznkRdzYTIIhRY4n2RaalMEYSxBl0bG7wzJskRp2gpslS7orCJlCGWQeQ-dpn3wqrCYs_CuzQ7hF5VV_4YGGIxq4s0VhrNvLVBOm5zzT06PKEQcejD2VpX5UObGqNsvrSlKnHCJSm1JKX24cdrTf6v-8laz2V3oBbl3-Xvw-mmGY8C_W_oytfP1CdROSIuHvfhqF2fjaRUIdJC1-jL-4N_hQ84imwZfifQWz49-2-IOpZmANtiJgbNthrAzq-L6dX1C9JP10Y
link.rule.ids 315,786,790,12083,12250,21416,27957,27958,31754,31755,33301,33302,33779,33780,43345,43614,43840,74102,74371,74659
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Nj9MwEB2x5cAeQAtl2UIBI6GeiEhiO7G5oKqiKtD2gFqpt8ifElI3KbQ99N8zTtJCD7ucPfIo49jzZvxmDPA-SVRqhTaRV5JHzHEdaY6Ba8pFEhyYMTTUDs_m2WTJvq34qk24bVta5fFMrA9qW5mQI8cgXYSy55yxz5tfUXg1Ktyutk9oXMBDRtHRhErx0Ynigfrqcmn0ajKilOZtj81YyI-lCkTKJA8N-viZT3ocSsZUWSIEDNTmu5Fn7YHGV_CkhY5k2Kz1U3jgymfQHaKO6vZABqQmc9ZZ8i40QNMdSOXJ9ueP-fATaTuArsk_PKEtUaUli5oN7iyOrANN4_AcluMvi9Ekal9KiAwCgB2eElQJqTOfa6MxoDHeWa0ThuhEiZymymaZSYTwsfA5c7GlzuVGZgYlM2dTeg2dsirdDRBEYEZlaSwVOndjvLDcMMUdhjk-y2Pfg8HRVsWmaYhR1BfZQhb4wUUwahGM2oMP55b8n3j_aOei3Ubb4u-i9-DdaRg3QLjVUKWr9kEmkQxxFo978KJZn5OmVCK-woDo5f2Tv4VHk8VsWky_zr-_gkucUTQcvz50dr_37jXijp1-U_9cfwDZINP7
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTxsxEB7xkCoOIEp4hEdxpYoTK_bltd1LFdFGQNuoqkDKbeWnVCndDSQ55N8z3nUCHICzLVsejz3f2N_MAHxJEpkarnTkpKBRbqmKFEXHNaU88QZM68zHDv8eFFd3-c2QDgP_aRJolYs7sbmoTa39Gzk66dyHPbM8v3CBFvHne__b-D7yFaT8T2sop7EK6zhJ7KsZsOGT80Xb0Gm0cCLKsoyFfJsxFxeV9KTKhPlkffSFfdr04WOyqhAOeprz6yi0sUb9bdgKMJL02n3_CCu22oFOD-eo_8_JGWmInc2LeQda0GnnpHZk8u_voPeVhGygI_KMMzQhsjLktmGGW4MtI0_ZmO_CXf_H7eVVFKomRBrBwBRvjExyoQrHlFbo3GhnjVJJjkhFcpal0hSFTjh3MXcst7HJrGVaFBp7Ftak2R6sVXVlD4AgGtOySGMh0dBr7bihOpfUosvjCha7LpwtZFWO2-QYZfOpzUWJCy69UEsv1C6cv5Tke92PF3Iuw5GalE8K0IXPy2Y8DP6HQ1a2nvk-icgRc9G4C_vt_ixnSgViLXSODt8e_BQ-oF6Vv64HP49gAwfkLd3vGNamDzN7ghBkqj41uvUI7vnYXA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Journey+of+siRNA%3A+Clinical+Developments+and+Targeted+Delivery&rft.jtitle=Nucleic+acid+therapeutics&rft.au=Nikam%2C+Rahul+R.&rft.au=Gore%2C+Kiran+R.&rft.date=2018-08-01&rft.pub=Mary+Ann+Liebert%2C+Inc&rft.issn=2159-3337&rft.eissn=2159-3345&rft.volume=28&rft.issue=4&rft.spage=29&rft.epage=224&rft_id=info:doi/10.1089%2Fnat.2017.0715&rft.externalDocID=10_1089_nat_2017_0715
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2159-3337&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2159-3337&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2159-3337&client=summon